scholarly article | Q13442814 |
P50 | author | David Nemazee | Q68011959 |
P2093 | author name string | David Nemazee | |
P2860 | cites work | B cell activation involves nanoscale receptor reorganizations and inside-out signaling by Syk | Q24299839 |
IRAK-4- and MyD88-dependent pathways are essential for the removal of developing autoreactive B cells in humans | Q24314442 | ||
The B-cell antigen receptor signals through a preformed transducer module of SLP65 and CIN85 | Q24319764 | ||
Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma | Q24613755 | ||
SLP-65: a new signaling component in B lymphocytes which requires expression of the antigen receptor for phosphorylation | Q24645697 | ||
The complete nucleotide sequence of the human immunoglobulin heavy chain variable region locus | Q24647015 | ||
Role of tyrosine phosphorylation of HS1 in B cell antigen receptor-mediated apoptosis | Q24669916 | ||
Interference with immunoglobulin (Ig)alpha immunoreceptor tyrosine-based activation motif (ITAM) phosphorylation modulates or blocks B cell development, depending on the availability of an Igbeta cytoplasmic tail | Q24675475 | ||
Basal immunoglobulin signaling actively maintains developmental stage in immature B cells | Q24795003 | ||
Polyreactive Antibodies: Function and Quantification | Q26999862 | ||
B lymphocyte antigen receptor signaling: initiation, amplification, and regulation | Q27022974 | ||
Biomarkers to guide clinical therapeutics in rheumatology? | Q28080053 | ||
Essential role of Src-family protein tyrosine kinases in NF-kappaB activation during B cell development | Q28206720 | ||
Receptor editing in a transgenic mouse model: site, efficiency, and role in B cell tolerance and antibody diversification | Q28259085 | ||
Receptor editing is the main mechanism of B cell tolerance toward membrane antigens | Q28262805 | ||
Polygenic autoimmune traits: Lyn, CD22, and SHP-1 are limiting elements of a biochemical pathway regulating BCR signaling and selection | Q28270723 | ||
C3d of complement as a molecular adjuvant: bridging innate and acquired immunity | Q28272810 | ||
The FoxO code | Q28275268 | ||
Signaling by the phosphoinositide 3-kinase family in immune cells | Q28283677 | ||
Cellular maturation defects in Bruton's tyrosine kinase-deficient immature B cells are amplified by premature B cell receptor expression and reduced by receptor editing | Q28504966 | ||
RAG-1 and ATM coordinate monoallelic recombination and nuclear positioning of immunoglobulin loci | Q28508203 | ||
Syk tyrosine kinase required for mouse viability and B-cell development | Q28586985 | ||
Regulation of B-lymphocyte negative and positive selection by tyrosine phosphatase CD45 | Q28592092 | ||
CD19 regulates Src family protein tyrosine kinase activation in B lymphocytes through processive amplification | Q28613558 | ||
Amplification of B cell antigen receptor signaling by a Syk/ITAM positive feedback loop | Q28613911 | ||
Somatic generation of antibody diversity | Q29616439 | ||
Predominant autoantibody production by early human B cell precursors | Q29619656 | ||
Visualization of Syk-antigen receptor interactions using green fluorescent protein: differential roles for Syk and Lyn in the regulation of receptor capping and internalization | Q31838023 | ||
B cell antigen receptor signaling and internalization are mutually exclusive events | Q33244376 | ||
B cells in autoimmune diseases: insights from analyses of immunoglobulin variable (Ig V) gene usage | Q33286220 | ||
Foxo1 directly regulates the transcription of recombination-activating genes during B cell development | Q33333434 | ||
Decoration of T-independent antigen with ligands for CD22 and Siglec-G can suppress immunity and induce B cell tolerance in vivo | Q33615157 | ||
Ras activation of Erk restores impaired tonic BCR signaling and rescues immature B cell differentiation | Q33730095 | ||
A disease-associated PTPN22 variant promotes systemic autoimmunity in murine models | Q36802757 | ||
The human immunoglobulin κ locus on yeast artificial chromosomes (YACs) | Q36870370 | ||
Specific peripheral B cell tolerance defects in patients with multiple sclerosis | Q36890946 | ||
B lymphocyte "original sin" in the bone marrow enhances islet autoreactivity in type 1 diabetes-prone nonobese diabetic mice | Q36920508 | ||
B-cell self-tolerance in humans | Q36942517 | ||
Phosphatase regulation of immunoreceptor signaling in T cells, B cells and mast cells | Q37066101 | ||
Monovalent and multivalent ligation of the B cell receptor exhibit differential dependence upon Syk and Src family kinases | Q37091486 | ||
Role of Syk in B-cell development and antigen-receptor signaling | Q37114681 | ||
Regulation of B-cell development and tolerance by different members of the miR-17∼92 family microRNAs | Q37153957 | ||
Basal B cell receptor-directed phosphatidylinositol 3-kinase signaling turns off RAGs and promotes B cell-positive selection. | Q37183404 | ||
CVID-associated TACI mutations affect autoreactive B cell selection and activation | Q37206886 | ||
A role for nuclear factor kappa B/rel transcription factors in the regulation of the recombinase activator genes. | Q37220784 | ||
NF-kappaB activity marks cells engaged in receptor editing | Q37292774 | ||
Efficient generation in vitro, from human peripheral blood cells, of monoclonal Epstein-Barr virus transformants producing specific antibody to a variety of antigens without prior deliberate immunization | Q37343139 | ||
Development of immunoglobulin lambda-chain-positive B cells, but not editing of immunoglobulin kappa-chain, depends on NF-kappaB signals | Q37344357 | ||
Distinct roles for E12 and E47 in B cell specification and the sequential rearrangement of immunoglobulin light chain loci | Q37377456 | ||
Regulation of B-cell proliferation and differentiation by pre-B-cell receptor signalling | Q37400609 | ||
Cracking the BAFF code. | Q37517172 | ||
Dual immunoglobulin light chain B cells: Trojan horses of autoimmunity? | Q37678661 | ||
Control systems and decision making for antibody production. | Q37774242 | ||
The establishment of early B cell tolerance in humans: lessons from primary immunodeficiency diseases | Q37974981 | ||
New insights into pre-BCR and BCR signalling with relevance to B cell malignancies | Q38123936 | ||
B cell receptor basal signaling regulates antigen-induced Ig light chain rearrangements | Q38292514 | ||
Regulation of immunoglobulin light-chain recombination by the transcription factor IRF-4 and the attenuation of interleukin-7 signaling. | Q38293488 | ||
Significant Differences in Physicochemical Properties of Human Immunoglobulin Kappa and Lambda CDR3 Regions | Q39301124 | ||
CIN85 is required for Cbl-mediated regulation of antigen receptor signaling in human B cells | Q39409241 | ||
Transgenic mice with immunoglobulin genes | Q39595449 | ||
Allelic exclusion in transgenic mice that express the membrane form of immunoglobulin mu | Q70338853 | ||
Editing disease-associated autoantibodies | Q73115270 | ||
A VH11V kappa 9 B cell antigen receptor drives generation of CD5+ B cells both in vivo and in vitro | Q73709074 | ||
Autoimmune NZB/NZW F1 mice utilize B cell receptor editing for generating high-affinity anti-dsDNA autoantibodies from low-affinity precursors | Q73852046 | ||
VpreB1/VpreB2/lambda 5 triple-deficient mice show impaired B cell development but functional allelic exclusion of the IgH locus | Q74261418 | ||
The PI3K p110delta is required for down-regulation of RAG expression in immature B cells | Q79717937 | ||
In vivo assessment of the relative contributions of deletion, anergy, and editing to B cell self-tolerance | Q80345129 | ||
Lupus susceptibility genes may breach tolerance to DNA by impairing receptor editing of nuclear antigen-reactive B cells | Q80582372 | ||
Impaired receptor editing in the primary B cell repertoire of BASH-deficient mice | Q80967853 | ||
Arginine methylation of the B cell antigen receptor promotes differentiation. | Q33794949 | ||
Redemption of autoantibodies on anergic B cells by variable-region glycosylation and mutation away from self-reactivity. | Q33835200 | ||
High throughput cellular screens to interrogate the human T and B cell repertoires | Q33907471 | ||
Activation of Ras overcomes B-cell tolerance to promote differentiation of autoreactive B cells and production of autoantibodies | Q33919653 | ||
A global network of transcription factors, involving E2A, EBF1 and Foxo1, that orchestrates B cell fate | Q33961160 | ||
Expansion of immunoglobulin-secreting cells and defects in B cell tolerance in Rag-dependent immunodeficiency | Q33979850 | ||
Bam32 Links the B Cell Receptor to ERK and JNK and Mediates B Cell Proliferation but Not Survival | Q34270517 | ||
Organization of the human immunoglobulin lambda light-chain locus on chromosome 22q11.2. | Q34303713 | ||
Clonal deletion of autoreactive B lymphocytes in bone marrow chimeras | Q34313426 | ||
The B lymphocyte adaptor molecule of 32 kilodaltons (Bam32) regulates B cell antigen receptor internalization | Q34360396 | ||
Antigen receptors on B lymphocytes | Q34420640 | ||
Responsiveness of B cells is regulated by the hinge region of IgD. | Q34470602 | ||
Ig beta tyrosine residues contribute to the control of B cell receptor signaling by regulating receptor internalization | Q34544332 | ||
Receptor editing in lymphocyte development and central tolerance. | Q34568574 | ||
Cis and trans regulatory mechanisms control AP2-mediated B cell receptor endocytosis via select tyrosine-based motifs | Q34571456 | ||
Oligomeric organization of the B-cell antigen receptor on resting cells | Q34623132 | ||
Allelic exclusion of immunoglobulin gene rearrangement and expression: why and how? | Q34772100 | ||
VH replacement in primary immunoglobulin repertoire diversification. | Q35062818 | ||
Pro-B cells sense productive immunoglobulin heavy chain rearrangement irrespective of polypeptide production | Q35081657 | ||
Activation-induced cytidine deaminase mediates central tolerance in B cells | Q35105238 | ||
HIV-1 envelope gp41 broadly neutralizing antibodies: hurdles for vaccine development | Q35172770 | ||
The PTPN22 allele encoding an R620W variant interferes with the removal of developing autoreactive B cells in humans | Q35187072 | ||
PTPN22: the archetypal non-HLA autoimmunity gene | Q35221741 | ||
Negative selection by IgM superantigen defines a B cell central tolerance compartment and reveals mutations allowing escape | Q35582239 | ||
The regulation of lupus-associated autoantibodies: immunoglobulin transgenic models | Q35589858 | ||
Expansion of autoreactive unresponsive CD21-/low B cells in Sjögren's syndrome-associated lymphoproliferation | Q35776056 | ||
Skewed primary Igκ repertoire and V-J joining in C57BL/6 mice: implications for recombination accessibility and receptor editing. | Q35784452 | ||
The microRNA miR-148a functions as a critical regulator of B cell tolerance and autoimmunity. | Q35930798 | ||
The scope of receptor editing and its association with autoimmunity | Q35931602 | ||
Control of the B cell-intrinsic tolerance programs by ubiquitin ligases Cbl and Cbl-b | Q35940280 | ||
B-cell tolerance defects in the B6.Aec1/2 mouse model of Sjögren's syndrome | Q35957443 | ||
Defective B cell tolerance in adenosine deaminase deficiency is corrected by gene therapy | Q36005403 | ||
The B-cell antigen receptor integrates adaptive and innate immune signals | Q36120391 | ||
The pre-B-cell receptor: selector of fitting immunoglobulin heavy chains for the B-cell repertoire | Q36184410 | ||
Reduced receptor editing in lupus-prone MRL/lpr mice | Q36229153 | ||
Activation-Induced Cytidine Deaminase Expression in Human B Cell Precursors Is Essential for Central B Cell Tolerance | Q36304376 | ||
Receptor editing: an approach by autoreactive B cells to escape tolerance | Q36361497 | ||
Receptor editing in self-reactive bone marrow B cells | Q36361578 | ||
B lymphocytes may escape tolerance by revising their antigen receptors | Q36361618 | ||
Light chain editing in kappa-deficient animals: a potential mechanism of B cell tolerance | Q36364008 | ||
Light chain replacement: a new model for antibody gene rearrangement | Q36365220 | ||
Entry of B cell receptor into signaling domains is inhibited in tolerant B cells. | Q36368404 | ||
Bruton's tyrosine kinase regulates the activation of gene rearrangements at the lambda light chain locus in precursor B cells in the mouse | Q36369010 | ||
Autoreactive B cells in the marginal zone that express dual receptors | Q36369869 | ||
Loss of the pro-apoptotic BH3-only Bcl-2 family member Bim inhibits BCR stimulation-induced apoptosis and deletion of autoreactive B cells | Q36371743 | ||
Changes in locus-specific V(D)J recombinase activity induced by immunoglobulin gene products during B cell development | Q36376789 | ||
Enforced Bcl-2 expression inhibits antigen-mediated clonal elimination of peripheral B cells in an antigen dose-dependent manner and promotes receptor editing in autoreactive, immature B cells | Q36380837 | ||
Syk tyrosine kinase is required for the positive selection of immature B cells into the recirculating B cell pool | Q36380979 | ||
Receptor editing and marginal zone B cell development are regulated by the helix-loop-helix protein, E2A | Q36399448 | ||
Human autoantibody silencing by immunoglobulin light chains | Q36399885 | ||
Receptor editing occurs frequently during normal B cell development. | Q36401586 | ||
Defective B cell tolerance checkpoints in systemic lupus erythematosus | Q36402748 | ||
Impaired early B cell tolerance in patients with rheumatoid arthritis. | Q36402969 | ||
Bruton's tyrosine kinase is essential for human B cell tolerance | Q36403841 | ||
ITAM-mediated tonic signalling through pre-BCR and BCR complexes | Q36430140 | ||
Rituximab does not reset defective early B cell tolerance checkpoints | Q36430775 | ||
Receptor editing and genetic variability in human autoreactive B cells. | Q36455313 | ||
A role for interferon regulatory factor 4 in receptor editing | Q36540253 | ||
RAG-mediated DNA double-strand breaks activate a cell type-specific checkpoint to inhibit pre-B cell receptor signals | Q36569363 | ||
TLR9 promotes tolerance by restricting survival of anergic anti-DNA B cells, yet is also required for their activation | Q36585700 | ||
Ordered rearrangement of immunoglobulin heavy chain variable region segments | Q36586574 | ||
The ataxia telangiectasia mutated kinase controls Igκ allelic exclusion by inhibiting secondary Vκ-to-Jκ rearrangements | Q36603553 | ||
STIM1, PKC-δ and RasGRP set a threshold for proapoptotic Erk signaling during B cell development. | Q36759087 | ||
Regulation of basement membrane-reactive B cells in BXSB, (NZBxNZW)F1, NZB, and MRL/lpr lupus mice | Q36763279 | ||
The BAFF receptor transduces survival signals by co-opting the B cell receptor signaling pathway. | Q36768345 | ||
Autoreactive IgG memory antibodies in patients with systemic lupus erythematosus arise from nonreactive and polyreactive precursors | Q36775342 | ||
The MAPK/ERK and PI3K pathways additively coordinate the transcription of recombination-activating genes in B lineage cells | Q39667386 | ||
Sin1-mTORC2 suppresses rag and il7r gene expression through Akt2 in B cells. | Q39668203 | ||
A self-reinforcing regulatory network triggered by limiting IL-7 activates pre-BCR signaling and differentiation | Q39793982 | ||
Autoreactive B cell receptors mimic autonomous pre-B cell receptor signaling and induce proliferation of early B cells | Q39904891 | ||
Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies. | Q40429324 | ||
Genetic and structural evidence for antigen selection of anti-DNA antibodies. | Q40661152 | ||
Lipid rafts unite signaling cascades with clathrin to regulate BCR internalization | Q40696448 | ||
Induction of the antigen receptor expression on B lymphocytes results in rapid competence for signaling of SLP-65 and Syk. | Q40987517 | ||
Checkpoints for Autoreactive B Cells in the Peripheral Blood of Lupus Patients Assessed by Flow Cytometry. | Q41103048 | ||
The "clonal selection hypothesis" and current concepts of B cell tolerance | Q41113352 | ||
Elimination from peripheral lymphoid tissues of self-reactive B lymphocytes recognizing membrane-bound antigens | Q41170875 | ||
Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. | Q41423746 | ||
Antigen presentation by the B cell antigen receptor is driven by the alpha/beta sheath and occurs independently of its cytoplasmic tyrosines | Q41528179 | ||
In-depth determination and analysis of the human paired heavy- and light-chain antibody repertoire | Q41602128 | ||
Co-receptor and accessory regulation of B-cell antigen receptor signal transduction. | Q41708790 | ||
BLNK binds active H-Ras to promote B cell receptor-mediated capping and ERK activation | Q41780823 | ||
CIN85 drives B cell responses by linking BCR signals to the canonical NF-kappaB pathway | Q41789207 | ||
PI3 kinase signals BCR-dependent mature B cell survival | Q41886641 | ||
Rearrangement of mouse immunoglobulin kappa deleting element recombining sequence promotes immune tolerance and lambda B cell production | Q41911438 | ||
Tonic BCR signaling represses receptor editing via Raf- and calcium-dependent signaling pathways | Q41969243 | ||
Overexpression of Fkbp11, a feature of lupus B cells, leads to B cell tolerance breakdown and initiates plasma cell differentiation | Q41991228 | ||
Transitional B cells are the target of negative selection in the B cell compartment | Q42026939 | ||
PTPN22 inhibition resets defective human central B cell tolerance | Q42059400 | ||
Phospholipase Cgamma2 contributes to light-chain gene activation and receptor editing | Q42124822 | ||
Antigenic liposomes displaying CD22 ligands induce antigen-specific B cell apoptosis. | Q42678843 | ||
Frequency and characterization of phenotypic Ig heavy chain allelically included IgM-expressing B cells in mice. | Q42799157 | ||
Reduced life span of anergic self-reactive B cells in a double-transgenic model | Q42942098 | ||
Unique signaling properties of B cell antigen receptor in mature and immature B cells: implications for tolerance and activation | Q43760103 | ||
Receptor editing in CD45-deficient immature B cells | Q44124111 | ||
The physiologic role of CD19 cytoplasmic tyrosines | Q44184966 | ||
Pten inactivation alters peripheral B lymphocyte fate and reconstitutes CD19 function | Q44379293 | ||
Unexpected requirement for ZAP-70 in pre-B cell development and allelic exclusion. | Q44410226 | ||
Modification of ligand-independent B cell receptor tonic signals activates receptor editing in immature B lymphocytes | Q44688347 | ||
Multiple checkpoint breach of B cell tolerance in Rasgrp1-deficient mice | Q46073605 | ||
Competition for follicular niches excludes self-reactive cells from the recirculating B-cell repertoire. | Q46109491 | ||
Regulation of B-cell development by BCAP and CD19 through their binding to phosphoinositide 3-kinase | Q46891828 | ||
Self-reactive B lymphocytes overexpressing Bcl-xL escape negative selection and are tolerized by clonal anergy and receptor editing. | Q47713262 | ||
Clustered arrangement of immunoglobulin λ constant region genes in man | Q48407182 | ||
Molecular components of the B-cell antigen receptor complex of the IgM class | Q50335807 | ||
A c-Myc/miR17-92/Pten Axis Controls PI3K-Mediated Positive and Negative Selection in B Cell Development and Reconstitutes CD19 Deficiency. | Q50502479 | ||
Block in development at the pre-B-II to immature B cell stage in mice without Ig kappa and Ig lambda light chain. | Q52110038 | ||
Developmental regulation of B lymphocyte immune tolerance compartmentalizes clonal selection from receptor selection. | Q52190945 | ||
In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death. | Q52192552 | ||
The site and stage of anti-DNA B-cell deletion. | Q52210540 | ||
Elimination of self-reactive B lymphocytes proceeds in two stages: arrested development and cell death. | Q52227004 | ||
Impaired NK1+ T cell development and early IL-4 production in CD1-deficient mice. | Q52525223 | ||
BCR-mediated apoptosis associated with negative selection of immature B cells is selectively dependent on Pten. | Q53455269 | ||
SLP-65 regulates immunoglobulin light chain gene recombination through the PI(3)K-PKB-Foxo pathway. | Q53959197 | ||
Defects in the CD19 complex predispose to glomerulonephritis, as well as IgG1 subclass deficiency | Q56939872 | ||
Contribution of Receptor Editing to the Antibody Repertoire | Q57198265 | ||
B cell deletion, anergy, and receptor editing in "knock in" mice targeted with a germline-encoded or somatically mutated anti-DNA heavy chain | Q57198310 | ||
A Prematurely Expressed Igκ Transgene, but Not a VκJκ Gene Segment Targeted into the Igκ Locus, Can Rescue B Cell Development in λ5-Deficient Mice | Q57198348 | ||
Surrogate Light Chain Expression Is Required to Establish Immunoglobulin Heavy Chain Allelic Exclusion during Early B Cell Development | Q57198364 | ||
Functional immunoglobulin transgenes guide ordered B-cell differentiation in Rag-1-deficient mice | Q57222709 | ||
Expression of anti-DNA immunoglobulin transgenes in non-autoimmune mice | Q59065295 | ||
Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes | Q59098044 | ||
Re-evaluation of the probabilities for productive rearrangements on the κ andλloci | Q63965565 | ||
P433 | issue | 5 | |
P304 | page(s) | 281-294 | |
P577 | publication date | 2017-04-03 | |
P1433 | published in | Nature Reviews Immunology | Q43355 |
P1476 | title | Mechanisms of central tolerance for B cells | |
P478 | volume | 17 |
Q88102887 | A cold-blooded view of adaptive immunity |
Q90289066 | Analysis of the B cell receptor repertoire in six immune-mediated diseases |
Q112034257 | Autoimmune Encephalitis in COVID-19 Infection: Our Experience and Systematic Review of the Literature |
Q33821526 | Autophagy and its link to type II diabetes mellitus |
Q90015400 | B Cell Responses: Cell Interaction Dynamics and Decisions |
Q91724262 | B cell signaling in context |
Q48300362 | B-cell receptor repertoire sequencing in patients with primary immunodeficiency: a review |
Q90341652 | BAFF inhibition in SLE-Is tolerance restored? |
Q42366322 | Bone marrow basophils provide survival signals to immature B cells in vitro but are dispensable in vivo |
Q58739031 | Can the Fact That Myelin Proteins Are Old and Break down Explain the Origin of Multiple Sclerosis in Some People? |
Q93049082 | Cell circuits and niches controlling B cell development |
Q97533806 | Cell death in chronic inflammation: breaking the cycle to treat rheumatic disease |
Q93000437 | Chromosome dynamics near the sol-gel phase transition dictate the timing of remote genomic interactions |
Q95327696 | Clonal expansion of innate and adaptive lymphocytes |
Q92932606 | Comparisons of the antibody repertoires of a humanized rodent and humans by high throughput sequencing |
Q57186351 | Control of autoreactive B cells by IgM and IgD B cell receptors: maintaining a fine balance |
Q88764721 | Designing natural and synthetic immune tissues |
Q92184345 | Detection and activation of HIV broadly neutralizing antibody precursor B cells using anti-idiotypes |
Q99637298 | Dynamic regulation of hypoxia-inducible factor-1α activity is essential for normal B cell development |
Q94483851 | Dynamics of heavy chain junctional length biases in antibody repertoires |
Q92245174 | Evaluation of a Fully Human, Hepatitis B Virus-Specific Chimeric Antigen Receptor in an Immunocompetent Mouse Model |
Q41461880 | Evidence for Ig Light Chain Isotype Exclusion in Shark B Lymphocytes Suggests Ordered Mechanisms. |
Q64068002 | Functional Roles of the IgM Fc Receptor in the Immune System |
Q89581789 | Gammaherpesvirus-infected germinal center cells express a distinct immunoglobulin repertoire |
Q54216895 | Hypomorphic Rag1 mutations alter the pre-immune repertoire at early stages of lymphoid development. |
Q90836400 | Immunogenicity of Protein Pharmaceuticals |
Q41925820 | Immunologic Insights on the Membrane Proximal External Region: A Major Human Immunodeficiency Virus Type-1 Vaccine Target. |
Q92488934 | Metabolic gatekeepers to safeguard against autoimmunity and oncogenic B cell transformation |
Q90323195 | Minding the gap: The impact of B-cell tolerance on the microbial antibody repertoire |
Q58789359 | Murine Bone Marrow Niches from Hematopoietic Stem Cells to B Cells |
Q92602559 | Mutations in topoisomerase IIβ result in a B cell immunodeficiency |
Q91588676 | Myasthenia Gravis: Pathogenic Effects of Autoantibodies on Neuromuscular Architecture |
Q91844402 | Peripheral B Cell Subsets in Autoimmune Diseases: Clinical Implications and Effects of B Cell-Targeted Therapies |
Q49805093 | Peripheral B-Cell Subset Distribution in Primary Antiphospholipid Syndrome |
Q42379035 | Phenotyping of autoreactive B cells with labeled nucleosomes in 56R transgenic mice. |
Q92528198 | Plasmodium asexual growth and sexual development in the haematopoietic niche of the host |
Q64984736 | Poly- and autoreactivity of HIV-1 bNAbs: implications for vaccine design. |
Q60927134 | Precocious expression of Blimp1 in B cells causes autoimmune disease with increased self-reactive plasma cells |
Q92279252 | Regulation of autoimmune disease by the E3 ubiquitin ligase Itch |
Q92118465 | Self-reactive B cells in the GALT are actively curtailed to prevent gut inflammation |
Q57191724 | Systemic ST6Gal-1 Is a Pro-survival Factor for Murine Transitional B Cells |
Q55030447 | Tailoring Immune Responses toward Autoimmunity: Transcriptional Regulators That Drive the Creation and Collusion of Autoreactive Lymphocytes. |
Q96641277 | Tet2 and Tet3 in B cells are required to repress CD86 and prevent autoimmunity |
Q98158848 | The B cell immunobiology that underlies CNS autoantibody-mediated diseases |
Q52581587 | The development of HIV vaccines targeting gp41 membrane-proximal external region (MPER): challenges and prospects. |
Q50158327 | The molecular basis of immune regulation in autoimmunity |
Q39386100 | The multiple pathways to autoimmunity |
Q92302527 | The role of B cells in multiple sclerosis: Current and future therapies |
Q89457645 | Trial watch: chemotherapy-induced immunogenic cell death in immuno-oncology |
Q89170045 | VprBP (DCAF1) Regulates RAG1 Expression Independently of Dicer by Mediating RAG1 Degradation |
Q60949578 | Yap1 safeguards mouse embryonic stem cells from excessive apoptosis during differentiation |